# Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

> **NCT00800332** · PHASE2 · COMPLETED · sponsor: **Cytos Biotechnology AG** · enrollment: 300 (estimated)

## Conditions studied

- Rhinoconjunctivitis
- Allergies

## Interventions

- **DRUG:** CYT003-QbG10
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00800332
- **Lead sponsor:** Cytos Biotechnology AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-11
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2010-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800332, "Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00800332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*